RRAS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.842130E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.053800E-02
Normal-vs-Stage2
3.042200E-02
Normal-vs-Stage3
1.084780E-01
Normal-vs-Stage4
1.572650E-01
Stage1-vs-Stage2
9.618000E-02
Stage1-vs-Stage3
9.379200E-01
Stage1-vs-Stage4
2.317800E-01
Stage2-vs-Stage3
5.874800E-01
Stage2-vs-Stage4
9.673000E-01
Stage3-vs-Stage4
4.263000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.661720E-02
Normal-vs-AfricanAmerican
1.024030E-01
Normal-vs-Asian
2.205900E-02
Caucasian-vs-AfricanAmerican
7.047800E-01
Caucasian-vs-Asian
1.257960E-01
AfricanAmerican-vs-Asian
7.663800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.889600E-01
Normal-vs-Female
5.147700E-02
Male-vs-Female
5.444800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.939400E-01
Normal-vs-Age(41-60Yrs)
6.622200E-01
Normal-vs-Age(61-80Yrs)
8.191600E-02
Normal-vs-Age(81-100Yrs)
1.828390E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.513200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.237200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.278800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.122000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.580810E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.849000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.276200E-01
Normal-vs-Daily Drinker
8.616000E-02
Normal-vs-Weekly Drinker
8.685000E-01
Normal-vs-Occasional Drinker
6.005600E-01
Normal-vs-Social Drinker
1.952000E-01
Non Drinker-vs-Daily Drinker
4.219800E-01
Non Drinker-vs-Weekly Drinker
4.681800E-01
Non Drinker-vs-Occasional Drinker
2.376800E-01
Non Drinker-vs-Social Drinker
8.414200E-01
Daily Drinker-vs-Weekly Drinker
3.734000E-01
Daily Drinker-vs-Occasional Drinker
6.816400E-02
Daily Drinker-vs-Social Drinker
6.207400E-01
Weekly Drinker-vs-Occasional Drinker
6.646400E-01
Weekly Drinker-vs-Social Drinker
4.422600E-01
Occasional Drinker-vs-Social Drinker
2.428600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.482200E-01
Normal-vs-Grade 2
5.665200E-01
Normal-vs-Grade 3
5.790800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.819930E-02
Grade 1-vs-Grade 3
1.517510E-03
Grade 1-vs-Grade 4
5.482200E-01
Grade 2-vs-Grade 3
9.030300E-02
Grade 2-vs-Grade 4
5.665200E-01
Grade 3-vs-Grade 4
5.790800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.405620E-01
Normal-vs-NonDiabetic
2.620300E-02
Diabetic-vs-NonDiabetic
3.216800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.863800E-02
Normal-vs-NoPancreatitis
1.415990E-02
Pancreatitis-vs-NoPancreatitis
7.986200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.445800E-02
Normal-vs-N1
4.762400E-02
N0-vs-N1
3.244300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.186800E-01
Normal-vs-TP53-NonMutant
3.298500E-02
TP53-Mutant-vs-TP53-NonMutant
2.640000E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
